Fylde and Wyre Policies

Click each header to expand its content

Commissioning Policies

Application Amendment Waiver of Policies for the Comm of Appropriate Effective and Priority Health Care 0.4 MB81
Commissioning Policies Introduction Document 89 KB110
Considering Applications For Exceptionality 0.3 MB160
General Policy IFR Decision Making 0.4 MB110
Policy for Assisted Conception Services 0.3 MB196
Policy for Benign Skin Lesion (updated September 2019) 0.2 MB91
Policy for Breast Reduction (updated September 2019) 0.2 MB54
Policy for Carpal Tunnel Syndrome updated October 2019 0.2 MB59
Policy for Chalazia Removal 0.2 MB85
Policy for Choice of Service Provide 0.2 MB113
Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain 0.6 MB97
Policy for Commissioning Spinal Injections and Radiofrequency Denervation for Low Back Pain 0.4 MB123
Policy for Complementary and Alternative Therapies 88 KB94
Policy for Complex Cases 0.2 MB89
Policy for Cosmetic Procedures (updated September 2019) 0.2 MB92
Policy for Dilatation and Curettage 45 KB73
Policy for Dupuytren's contracture 0.3 MB95
Policy for Endoscopic Procedures on the Knee Joint Cavity 0.2 MB84
Policy for excision of the uterus 0.1 MB83
Policy for ganglia excision 0.2 MB71
Policy for Glucose Monitoring Devices (March 19 amends) 0.3 MB188
Policy for Grommets (updated September 2019) 0.2 MB29
Policy for Gynaecomastia (updated September 2019) 0.2 MB34
Policy for Haemorrhoid surgery 0.2 MB76
Policy for Hip Arthroscopy 42 KB100
Policy for hysteroscopy 0.1 MB42
Policy for insulin pump provision 0.1 MB72
Policy for Low Intensity Pulsed Ultrasound (LIPUS) Therapy (updated January 2020) 0.3 MB1
Policy for Lumbar spine procedures 0.3 MB75
Policy for Male Circumcision 0.2 MB117
Policy for Monitoring and Enforcing CCG Policies 0.1 MB87
Policy for photorefractive surgery 0.1 MB77
Policy for Reversal of Sterilisation 0.1 MB41
Policy for services that are the subject of guidance from NICE 0.1 MB118
Policy for snoring surgery 0.2 MB70
Policy for Specified Expensive Services 0.1 MB85
Policy for Specified Non-clinical issues 0.1 MB90
Policy for Specified Services for which provision in service agreements may be limited 0.2 MB109
Policy for Surgical Release of Trigger Finger (updated September 2019) 0.2 MB44
Policy for testing for Malignant Hyperthermia 0.1 MB110
Policy for Tonsillectomy (updated September 2019) 0.2 MB56
Policy for varicose veins 0.2 MB45
Policy Process map appeals 0.1 MB82
Policy Spinal Cord Stimulation 38 KB128
Policy subacromial decompression 0.2 MB69
Statement Of Principles 0.3 MB83

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

Actipatch for pain management 0.6 MB183
Albiglutide for type-2 diabetes mellitus 0.3 MB119
Alprostadil Cream For ED 0.3 MB96
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB153
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB108
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB116
Brimonidine For Erythema Of Rosacea 0.1 MB104
Brivaracetam for epilepsy 0.3 MB105
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB136
Certolizumab For Psoriatic Arthritis 0.1 MB86
Co-Proxamol For pain management 0.3 MB222
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB110
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB112
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB105
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB75
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB219
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB76
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB80
Denosumab for GIO 0.2 MB58
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB116
Eflornithine-cream-for-facial-hirsutism 0.2 MB105
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB68
Eslicarbazepine For Focal Seizures 0.1 MB91
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB106
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB108
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB65
Gluten-Free-Food-Products 0.3 MB105
Guanfacine-for-ADHD 0.3 MB91
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB90
Insulin Degludec And Liraglutide 0.2 MB87
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB99
Insulin-Degludec-for-DM 0.3 MB101
Insulin-Detemir-for-DM 0.2 MB75
Insuline-Glargine-for-T1DM 0.3 MB79
Insuline-Glargine-for-T2DM 0.3 MB84
Invicorp-injection-for-erectile-dysfunction 0.3 MB115
Ivermectin-cream-for-rosacea 0.3 MB98
JIA Policy For Adults (Version 1.0) 0.2 MB74
Lamotrigine-for-trigeminal-neuralgia 0.3 MB91
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB113
Levonorgestrel 13.5mg IUD 0.3 MB73
Lidocaine Plasters For PHN 0.2 MB84
Lidocaine-plasters-for-unlicensed-indications 0.3 MB156
Liothyronine-for-refractory-hypothyroidism 0.2 MB122
Liraglutide-for-obesity 0.3 MB99
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB104
Lisdexamfetamine-for-ADHD-update 0.3 MB89
Lurasidone-for-Schizophrenia 0.3 MB110
Magnaspartate For Hypomagnesaemia 0.3 MB158
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB81
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB65
Midazolam-Epistatus-for-seizures 0.2 MB109
Opicapone-for-Parkinsons-disease-v2 0.5 MB117
Ospemifene for VVA 0.2 MB106
Oxycodone-Naloxone-for-Restless-legs 0.3 MB79
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB281
Patiromer-for-hyperkalaemia 0.3 MB81
Patiromer-for-hyperkalaemia 2 0.3 MB102
Phosphodiesterase Type-5 Inhibitors 0.2 MB72
Pitolisant-for-Narcolepsyv2 0.3 MB86
Policy On Brand Inhaler Prescribing 0.3 MB105
Probiotics And VSL 0.3 MB91
Relvar Ellipta for COPD and asthma in adults 63 KB75
Rituximab-for-AIHA 0.4 MB103
Rituximab-for-ITP 0.4 MB87
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB95
Safinamide-for-Parkinsons-disease 0.3 MB109
Second Line Anti-TNF For PsA 0.2 MB92
Second-generation-LA-antipsychotics 0.3 MB106
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB78
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB84
Semaglutide for type 2 DM 0.2 MB54
Silk Garments For Eczema And Dermatitis 0.2 MB74
Simbrinza for chronic open angle glaucoma 0.1 MB69
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB99
Spironolactone For Acne 0.1 MB102
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB88
Tadalafil daily 0.3 MB117
Tapentadol for neuropathic pain in non-palliative care 0.4 MB104
Tapentadol for non-specific pain 0.2 MB91
Testosterone For Female Sexual Dysfunction 0.1 MB65
Tiotropium For Asthma 0.2 MB69
Tocilizumab SC For RA 0.1 MB69
Trelegy inhaler for COPD 0.3 MB107
Trimbow inhaler for COPD 0.4 MB111
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB93
Umeclidinium For COPD 0.2 MB65
Vedolizumab For Crohn's Disease 0.2 MB59
Vesomni For Benign Prostatic Hyperplasia 0.1 MB75
Vitamins (inc Renavit) For Dialysis 0.3 MB107
Waterproof Cast Cover Policy 0.1 MB158
Xonvea for nausea and vomiting in pregnancy 0.1 MB58

Last updated on 17 September 2019 at 15:48 by communications manager